Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)

Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

<< Previous

Bullboard Posts

Next >>

Post by G1945Von Sep 08, 2020 8:26am

197 Views

Post# 31519210

Globe Newswire

Resverlogix Announces Participation at the Upcoming Global Chinese Financial Forum (“GCFF”) Virtual Conference 2020 – Investing in Innovation

CALGARY, Alberta, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces its participation at the GCFF Virtual Conference 2020 - Investing in Innovation (“GCFF Virtual Conference”) on September 10, 2020. Donald McCaffrey, the Company’s President and CEO, will provide a live video presentation commencing at 10:35 am PST / 1:35 pm EST.

About the GCFF Virtual Conference 2020 - Investing in Innovation

Registration for the GCFF Virtual Conference is complimentary and recommended to be made in advance by using the link HERE. Registration will close one day before the event.

The GCFF Virtual Conference, held on September 10, 2020, will connect Chinese investors living throughout North America to the latest investment opportunities in the fast growing innovative sectors of healthcare, life science, technology, clean technology, fintech and cannabis. Hosted by NAI Interactive Ltd., the bilingual online event will feature public and private company investment opportunities and will be broadcast in English and Mandarin Chinese.

An archived link to the presentation will be made available approximately one week after the live event on the Company website HERE.

G1945V